Prymula, Roman <br/><br/>
Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines.  [electronic resource] 

 -  Vaccine  Aug 2008 
 - 4563-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2008.05.080  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Bacterial--blood<br/>Bacterial Proteins--immunology<br/>Carrier Proteins--immunology<br/>Double-Blind Method<br/>Female<br/>Haemophilus Vaccines--adverse effects<br/>Hepatitis A Vaccines--immunology<br/>Humans<br/>Immunization, Secondary<br/>Immunoglobulin D--immunology<br/>Infant<br/>Lipoproteins--immunology<br/>Male<br/>Pneumococcal Vaccines--adverse effects<br/>Vaccines, Conjugate--immunology